Patent US658022A successfully refreshed from Google Patents.
US4015000A
Expired / Lapsed
US
⏱️ 0.0 years remaining
6-Acylamino-penam-3-carboxylic and 7-acylamino-3-cephem-4-carboxylic acids
Assignee: Novartis Corp
•
Filing: 1973-09-18
•
Granted: 1977-03-29
•
Expires: 1993-09-18
Abstract
Abstract 6-Acylamino-penam-3-carboxylic acids and 7-acylamino-3-cephem-4-carboxylic acids in which the acyl group has the formula ##STR1## IN WHICH R 1 is hydrogen, R 2 is optionally substituted phenyl, thienyl or furyl or R 1 and R 2 together are optionally substituted cycloalkyl, n and m independently of one another represent 0 or 1 and B represents an optionally substituted 2,6-dioxo- or 2,6-dithioxo-1,2,3,6-tetrahydro-pyrimidyl, 2-thioxo-6-oxo-1,2,3,6-tetrahydropyrimidyl, 2,6-dihydroxy- or 2,6-dimercapto-pyrimidyl, 2-mercapto-6-hydroxy-pyrimidyl, 2,6-diaminopyrimidyl, 2-amino-6-hydroxy-pyrimidyl or 2,6-dihalogenopyrimidyl radical, these radicals being bonded in the 4- or 5-position.
Inventors
- 👤 Karoly Kocsis
- 👤 Bruno Fechtig
- 👤 Hans Bickel
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-04 09:01
CPC Classifications
C; C07; C07D; C07D499/00
Claims Analysis
Total Claims: 12
Claim 1
Independent Claim
135 words
A compound of the formula I ##STR11## wherein the grouping -S-A- represents a radical of the formula Ib ##STR12## wherein R 3 denotes a carboxyl group andR 4 represents hydrogen, methyl, lower alkanoyloxymethyl, benzoylthiomethyl, pyridiniummethyl, 1-oxidized-2-pyridylthiomethyl, or pyridiniummethyl or 1-oxidized-2-pyridylthiomethyl substituted by lower alkyl, hydroxy, chloro, carboxy or carbamoyl, and wherein, if the radicals R 1 and R 2 are separate, R 1 is hydrogen and R 2 is phenyl, thienyl or furyl and, if the radicals R 1 and R 2 are linked, they form, together with the carbon atom, cycloalkyl ring with 4 to 7 carbon atoms, and wherein m represents 0 or 1, n represents 1 and B represents 2,4-dioxo-1,2,3,4-tetrahydro-pyrimidyl, 2,6-dioxo-1,2,3,6-tetrahydro-pyrimidyl, 2,4-dihydroxy-pyrimidyl, 2,6-dihydroxy-pyrimidyl, 2,6-dithioxo-1,2,3,6-tetrahydro-pyrimidyl, 2,6 dimethoxy-pyrimidyl, 2,6-dichloropyrimidyl, 2-methylthio-6-chloro-pyrimidyl, 2-methylthio-6-hydroxypyrimidyl, 2,6-bis-morpholino-4-pyrimidyl, and therapeutically acceptable alkali, alkaline earth metal, ammonium and inner salts thereof.
Claim 2
Dependent Claim
135 words
A compound of the formula I ##STR11## wherein the grouping -S-A- represents a radical of the formula Ib ##STR12## wherein R 3 denotes a carboxyl group andR 4 represents hydrogen, methyl, lower alkanoyloxymethyl, benzoylthiomethyl, pyridiniummethyl, 1-oxidized-2-pyridylthiomethyl, or pyridiniummethyl or 1-oxidized-2-pyridylthiomethyl substituted by lower alkyl, hydroxy, chloro, carboxy or carbamoyl, and wherein, if the radicals R 1 and R 2 are separate, R 1 is hydrogen and R 2 is phenyl, thienyl or furyl and, if the radicals R 1 and R 2 are linked, they form, together with the carbon atom, cycloalkyl ring with 4 to 7 carbon atoms, and wherein m represents 0 or 1, n represents 1 and B represents 2,4-dioxo-1,2,3,4-tetrahydro-pyrimidyl, 2,6-dioxo-1,2,3,6-tetrahydro-pyrimidyl, 2,4-dihydroxy-pyrimidyl, 2,6-dihydroxy-pyrimidyl, 2,6-dithioxo-1,2,3,6-tetrahydro-pyrimidyl, 2,6 dimethoxy-pyrimidyl, 2,6-dichloropyrimidyl, 2-methylthio-6-chloro-pyrimidyl, 2-methylthio-6-hydroxypyrimidyl, 2,6-bis-morpholino-4-pyrimidyl, and therapeutically acceptable alkali, alkaline earth metal, ammonium and inner salts thereof.
Claim 3
Dependent Claim
95 words
Compounds of the formula I as claimed in claim 1, wherein -S-A- represents a radical of the formula Ib ##STR13## wherein R 3 denotes a free carboxyl group and R 4 denotes a member selected from the group consisting of methyl, acetoxymethyl, benzoylthiomethyl, 1-oxidized-2-pyridylthiomethyl, or 1-oxidized-2-pyridylthiomethyl substituted by lower alkyl, hydroxy, chloro, carboxy or carbamoyl and wherein n = 1 andm = 0, R 1 represents hydrogen, R 2 represents phenyl, thienyl(2) or furyl(2) and B has the meaning indicated in claim 1, and therapeutically acceptable alkali, alkaline earth metal, ammonium and inner salts thereof.
Claim 4
Dependent Claim
84 words
Compounds of the formula I as claimed in claim 1, wherein -S-A- represents a radical of the formula Ib ##STR14## wherein R 3 denotes a carboxyl group and R 4 denotes pyridiniummethyl or pyridiniummethyl substituted by lower alkyl, hydroxy, chloro, carboxy or carbamoyl and wherein n = 1 and m = 0, R 1 represents hydrogen, R 2 represents phenyl, thienyl(2) or furyl(2) and B has the meaning indicated in claim 1, and therapeutically acceptable alkali, alkaline earth metal, ammonium and inner salts thereof.
Claim 5
Dependent Claim
84 words
Compounds of the formula I as claimed in claim 1, wherein -S-A- represents a radical of the formula Ib, wherein R 3 denotes a free carboxyl group and R 4 denotes a methyl, methoxy, acetoxymethyl, pyridiniummethyl or pyridiniummethyl substituted by lower alkyl, hydroxy, chloro, carboxy, or carbamoyl, and n = 1, m = 0, R 1 represents hydrogen and R 2 represents phenyl and B has the meaning indicated in claim 1, and therapeutically acceptable alkali, alkaline earth metal, ammonium and inner salts thereof.
Claim 6
Dependent Claim
83 words
Compounds of the formula I as claimed in claim 1, wherein -S-A- represents a radical of the formula Ib, wherein R 3 denotes a carboxyl group and R 4 denotes a methyl, methoxy, acetoxymethyl, benzoylthiomethyl, pyridiniummethyl, 1-oxidized-2-pyridylthiomethyl or pyridiniummethyl or 1-oxidized-2-pyridylthiomethyl substituted by lower alkyl, hydroxy, chloro, carboxy or carbamoyl, n = 1, m = 0, R 1 represents hydrogen and R 2 represents phenyl and B denotes 1,2,3,6-tetrahydro-2,6-dioxopyrimidyl(4) or 1,2,3,4-tetrahydro-2,4-dioxopyrimidyl(5), and therapeutically acceptable alkali, alkaline earth metal, ammonium and inner salts thereof.
Claim 7
Dependent Claim
23 words
A compound as claimed in claim 1, which is 7-[D(-)-α-1,2,3,6-tetrahydro-2,6dioxo-4-pyrimidine-carboxamido)-phenylacetamido]-cephalosporanic acid or a therapeutically acceptable alkali earth metal, ammonium or inner salt thereof.
Claim 8
Dependent Claim
25 words
A compound as claimed in claim 1, which is 7-[d(-)-α-1,2,3,4-tetrahydro-2,4-dioxo-5-pyrimidine-carboxamido)-penylacetamido -cephalosporanic acid or a therapeutically acceptable alkali, alkaline earth metal, ammonium or inner salt thereof.
Claim 9
Dependent Claim
29 words
A compound as claimed in claim 1, which is 7-[D(-)-α-1,2,3,4-tetrahydro-2,4-dioxo-5-pyrimidine-carboxamido)-phenylacetamido]-3-(1-pyridylmethyl)-ceph-3-em-4-carboxylic acid in the form of the betaine or a therapeutically acceptable alkali, alkaline earth metal or ammonium salt thereof.
Claim 10
Dependent Claim
29 words
A compound as claimed in claim 1, which is 7-]D(-)-α-1,2,3,6-tetrahydro-2,6-dioxo-4-pyrimidine-carboxamido)-phenylacetamido]-3-(1-pyridylmethyl)-ceph-3-em-4-carboxylic acid in the form of the betaine or a therapeutically acceptable alkali, alkaline earth metal or ammonium salt thereof.
Claim 11
Dependent Claim
28 words
A compound as claimed in claim 1, which is 7-[D(-)-α-1,2,3,4-tetrahydro-2,4-dioxo-5-pyrimidine-carboxamido)-phenylacetamido]-3-[1-(4-carbamoylpyridiniomethyl)]-ceph-3-em-4-carboxylic acid in the form of the betaine or a therapeutically alkali, alkaline earth metal or ammonium salt thereof.
Claim 12
Dependent Claim
36 words
An antibacterial pharmaceutical preparation which contains a therapeutically effective amount of a compound as claimed in claim 1 or a therapeutically acceptable alkali, alkaline earth metal, ammonium or inner salt thereof and a pharmaceutically acceptable excipient.
References Cited (Backward Citations)
US3322749A
Cited
US3499893A
Cited
US3833570A
Cited
US3825536A
Cited
US3873523A
Cited
DE2362816A1
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1980-03-28 | 1980-09-27 | 1981-03-29 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1984-03-28 | 1984-09-27 | 1985-03-29 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1988-03-28 | 1988-09-27 | 1989-03-29 | $7700.00 | Window Closed / Lapsed |